Nothing Special   »   [go: up one dir, main page]

US20050055008A1 - Swabbable needleless vial access - Google Patents

Swabbable needleless vial access Download PDF

Info

Publication number
US20050055008A1
US20050055008A1 US10/236,782 US23678202A US2005055008A1 US 20050055008 A1 US20050055008 A1 US 20050055008A1 US 23678202 A US23678202 A US 23678202A US 2005055008 A1 US2005055008 A1 US 2005055008A1
Authority
US
United States
Prior art keywords
plug
bore
stopper
port
accessing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/236,782
Inventor
Joseph Paradis
Dana Marshall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/236,782 priority Critical patent/US20050055008A1/en
Publication of US20050055008A1 publication Critical patent/US20050055008A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096Combination of a vial and a syringe for transferring or mixing their contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1406Septums, pierceable membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1412Containers with closing means, e.g. caps
    • A61J1/1425Snap-fit type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1475Inlet or outlet ports
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1475Inlet or outlet ports
    • A61J1/1481Inlet or outlet ports with connection retaining means, e.g. thread or snap-fit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1475Inlet or outlet ports
    • A61J1/1487Inlet or outlet ports with friction fit, e.g. connecting tubes directly to a protruding port
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/18Arrangements for indicating condition of container contents, e.g. sterile condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/04Access sites having pierceable self-sealing members
    • A61M39/045Access sites having pierceable self-sealing members pre-slit to be pierced by blunt instrument
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1468Containers characterised by specific material properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22Valves or arrangement of valves
    • A61M39/26Valves closing automatically on disconnecting the line and opening on reconnection thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5082Test tubes per se
    • B01L3/50825Closing or opening means, corks, bungs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S604/00Surgery
    • Y10S604/905Aseptic connectors or couplings, e.g. frangible, piercable

Definitions

  • the invention relates to coupling systems for the transfer of materials from one unit to another, and, more particularly, to coupling units with a first unit including a swabbable access port and a second unit including a blunt cannula.
  • the access port receives the blunt cannula to effect a coupling of particular medicinal applicability for medications and body fluids.
  • the swabbability of the access port allows disinfectant treatment before receipt of the blunt cunnula to limit the extent to which pathogens can enter the cannula after coupling is effected.
  • containers for medication typically are bottles capped with rubber-like stoppers.
  • a tamper-evident seal surrounds the stopper and at least the upper portion of the container.
  • a syringe with a needle or cannula is used to puncture the rubber stopper and withdraw a proper dosage for administration to a patient.
  • a related object is to reduce the hazards associated with removal of medication from sealed containers.
  • pointed needles or cannulae have been widely used in conjunction with other forms of access ports, which take the form of a septum or pierceable membrane.
  • An illustrative access port that is used with a pierceable cannula is disclosed in Zdeb U.S. Pat. 4,412,573 “Injection Site” assigned to Baxter International Inc. of Deerfield, Ill.
  • the pointed cannula can be forced through the septum in order to establish fluid communication between the cannula and the container housing a medicinal substance.
  • Access ports that are pierced by a cannula can be physically damaged by repetitive piercings and produce coring or laceration of the access port, which can result in leakage.
  • the access ports take the form of rubber stoppers which are routinely entered using conventional hypodermic needles.
  • the stopper is swabbed with a disinfectant before there is a needle entry. After repeated entries, the stopper can leak because of coring and no longer function as a swabbable sterile barrier.
  • particulate matter can be generated and injected into a patient, along with pathogens.
  • the pathogens and particulate matter may contaminate the contents of the vial.
  • pointed cannulae used with drug vials pose a health risk to their users because of problems associated with infectious agents. Despite the fact that personnel using pointed cannulae do so with great care, from time to time accidents occur, and the users are jabbed or suffer needle sticks. Used needles also present a risk of injury and handling problems for health care facility maintenance and waste removal personnel.
  • dispensing pins can be used to penetrate the site or stopper of multiple dose vials.
  • a dispensing pin typically takes the shape of a sharp spike and can be used with a check valve to limit fluid leakage.
  • One end of the spike has standard Luer fitment that is typically closed off, when not in use, by a cap.
  • Dispensing pins tend to disengage from the vial stopper with resultant leakage. Further, it is difficult to maintain sterile conditions on this kind of multiple dose system.
  • Injection sites used with a blunt cannula have the advantage that the cannula will not pierce the skin of a user, but the pre-slit injection site has to reseal with enough force that fluids do not ooze outwardly and not allow airborne particulate matter, bacterial or viral, to enter.
  • an injection site which can be used with a variety of solutions and over a range of fluid pressures. Further, there continues to be a need for such an injection site, which will reliably reseal even after many insertions of a blunt cannula and reduces the danger of contamination by dangerous pathogens.
  • the injection site should be able to receive a large number of insertions of the cannula without displaying reseal failure Such an injection site should provide for alignment of the cannula on insertion to result in less chance of damage to the injection site after repeated insertions.
  • pointed cannulae desirably are to be avoided, in some situations they may be the only ones available, so that the injection site also should be usable with pointed cannulae.
  • the injection site should be usable with a blunt cannula with a reasonable level of insertion force that will permit health care personnel to readily insert the cannula, but yet not have the cannula easily displaced after insertion.
  • Pre-Slit Injection Site in which one end of a housing carries a pre-slit septum, and a second end has a coupling to adapt the housing to standard vials.
  • the coupling or a vial adapter includes a spike with opening that allows drainage of fluid in the vial through the spike and into the injection site.
  • the vial adapter has a skirt, which protects the adapter spike in both manufacture and use.
  • the skirt also permits locking engagement of the adapter with injection site to standard vials, despite dimensional variations in vial closures
  • the coupling spike can have a barb that can be inserted into a standard vial and resist disengagement.
  • a blunt cannula is used with the combination of the injection site with the coupling. This system is both complex and cumbersome.
  • the invention provides for a cleansable, i.e., swabbable, access port, formed by a stopper having a bore extending from an entry position to an exit position; and a plug in the bore at the entry position and movable in the bore; whereby the location of the plug at the entry position of the stopper permits the cleansing or swabbing of the outer surfaces of the plug and the stopper before the plug is depressed into the bore of the stopper in order to reduce the danger of contamination of the bore by pathogens.
  • a cleansable i.e., swabbable, access port
  • the swabbable plug extends integrally across the bore and can be frangibly connected to the bore, or be slidably connected to the bore.
  • the swabbable plug has a non-planar external surface and is pierceable by a cannula or needle.
  • the stopper can have a collar at the entry position, and the collar can have external Luer threads.
  • a stretchable and apertured membrane can span the exit position of the bore so that when the plug is depressed into the bore by, for example the end of a fitment, the plug can be restored to its original, swabbable position at the entry position of the stopper when the fitment is removed.
  • the steps include (a) swabbing or cleansing a movable plug positioned in the bore of a stopper, for which the bore extends from an entry position, where the plug is swabbed, to an exit position; and (b) moving the plug within the bore away from the entry position; whereby communication can be established along the bore between the entry position and the exit position.
  • the method further includes the step of swabbing an integral surface of the movable plug, with the surface extending integrally across the bore.
  • the swabbing can be with respect to frangible connections to the bore.
  • further steps include slidably moving the plug along the bore; engaging the plug by a fitment with a transverse gap between a portion of the exterior surface of the plug and the engagement end of the fitment; and piercing the plug by a cannula.
  • the steps include engaging a collar of the stopper at the entry position of the bore; engaging external Luer threads of the collar; stretching an apertured membrane that spans the exit position of the bore; and causing fluid to flow in an auxiliary channel of the bore when the plug is depressed in the bore.
  • a system of the invention for the transfer of medication from a container includes (a) a needleless syringe having a blunt tubular end; (b) a stopper positioned in a neck portion of the container and having a central throughbore extending from an outer surface of the stopper to the interior of the container; (c) a plug extending into the bore from the outer surface of the stopper; (d) protrusions on the plug for engagement by the end of the syringe permitting fluid flow between the syringe and the plug; and (e) an auxiliary channel in the bore permitting the fluid flow to extend between the container and the syringe.
  • the invention enables the needleless and disinfected transfer of medication using a stopper with a movable plug having an integral surface for engagement of the plug by a fitment, such as the Luer end of a syringe.
  • medication can be withdrawn from a container with or without the use of a needle, after disinfectant treatment of the engagement surface of the plug to remove pathogens and possible contaminants.
  • single use vial or container access is transformed to multi-use vial or container access by replacing a single-use access plug with a swabbable, needleless, multiple-use lock connector.
  • FIG. 1A is a plan view of a stoppered medicinal container in accordance with the invention.
  • FIG. 1B is a top view of the stoppered medicinal container of FIG. 1A ;
  • FIG. 1C is a partial sectional view of the stoppered medicinal container of FIG. 1A ;
  • FIG. 2A is a full-scale side view of the stopper and plug of the medicinal container of FIG. 1A ;
  • FIG. 2B is a full-scale top view of the stopper and plug of the medicinal container of FIG. 1A ;
  • FIG. 2C is an enlarged sectional view of the stopper of the medicinal container of FIG. 1A ;
  • FIG. 2D is a partial top view of the stopper of FIG. 2C ;
  • FIG. 2D is a partial bottom view of the stopper of FIG. 2C ;
  • FIG. 2F is an enlarged, partial sectional view of an alternative stopper collar portion of the invention.
  • FIG. 2G is an enlarged sectional view of an alternative stopper for the container of FIG. 1C :
  • FIG. 3A is a full-scale side view of the plug of the stopper of FIG. 2A ;
  • FIG. 3B is a full-scale top view of the plug of the stopper of FIG. 2A ;
  • FIG. 3C is an enlarged view of the plug of FIG. 3A :
  • FIG. 3D is an enlarged view of the plug of FIG. 3B ;
  • FIG. 3E is a sectional view of the plug of FIG. 3C :
  • FIG. 4A is an enlarged, partial sectional view of the container of FIG. 1C preparatory to activation by a Luer fitment;
  • FIG. 4B is an enlarged, partial sectional view of the container of FIG. 1C during activation by a Luer fitment
  • FIG. 5A is a plan view of an alternative, stoppered medicinal container in accordance with the invention.
  • FIG. 5B is top view of the stoppered medicinal container of FIG. 5A ;
  • FIG. 5C is a partial sectional view of the stoppered medicinal container of FIG. 5A ;
  • FIG. 6A is a full-scale side view of the stopper and plug of the medicinal container of FIG. 5A :
  • FIG. 6B is a full-scale top view of the stopper and plug of the medicinal container of FIG. 5A ;
  • FIG. 6C is an enlarged sectional view of the stopper and plug of the medicinal container of FIG. 5A ;
  • FIG. 6D is a partial top view of the stopper and plug of FIG. 6C ;
  • FIG. 6E is a partial bottom view of the stopper of FIG. 6C ;
  • FIG. 6F is an enlarged, partial sectional view showing the alternative stopper for the container of FIG. 5C ;
  • FIG. 7A is an enlarged, partial sectional view of the container of FIG. 5C preparatory to activation by a Luer fitment;
  • FIG. 7B is an enlarged, partial sectional view of the container of FIG. 5C during activation by a Luer fitment
  • FIG. 8A is a partial sectional view of the container of FIG. 1C during activation by a cannula;
  • FIG. 8B is a partial sectional view of the container of FIG. 1C during activation by a Luer fitment
  • FIG. 8C is a partial sectional view of the container of FIG. 5C during activation by a cannula;
  • FIG. 8D is a partial sectional view of the container of FIG. 5C during activation by a Luer fitment
  • FIG. 9A is an enlarged, partial sectional view of another alternative embodiment of the invention preparatory to activation by a Luer fitment
  • FIG. 9B is an enlarged, partial sectional view of another alternative embodiment of the invention during activation by a Luer fitment
  • FIG. 9C is a partial sectional view of the bottom of the stopper and plug combination of FIGS. 9A and 9B ;
  • FIG. 10A is an enlarged, partial sectional view of still another alternative embodiment of the invention preparatory to activation by a Luer fitment;
  • FIG. 10B is an enlarged, partial sectional view of another alternative embodiment of the invention during activation by a Luer fitment
  • FIG. 10C is a partial sectional view of the bottom of the stopper and plug combination of FIG. 10A ;
  • FIG. 11A is a partial sectional view of an alternative, single-use vial in accordance with the invention.
  • FIG. 11B is a partial sectional view illustrating use of the single-use vial of FIG. 11A ;
  • FIG. 12A is a partial sectional view of an alternative, multiple-use vial in use in accordance with the invention.
  • FIG. 12B a sectional view of the central adapter for the multiple-use vial of FIG. 12A ;
  • FIG. 13A is a full scale top view of the central adapter of FIG. 12B ;
  • FIG. 13B is a full scale side view of the central adapter of FIG. 13A ;
  • FIG. 14A is an enlarged top view of the central adapter of FIG. 12B
  • FIG. 14B is a sectional view, taken along the lines 14 B- 14 B of FIG. 14A , of the central adapter of FIG. 14A ;
  • FIG. 15A is an alternative view of the central adapter of FIG. 14A , after rotation through 90 degrees;
  • FIG. 15B is a sectional view, taken along the lines 15 B- 15 B of FIGS. 14A and 15B , of the central adapter of FIGS. 14A and 15A ;
  • FIG. 16A is an enlarged sectional view of the moveable plastic plug of FIGS. 11A, 11B and 12 A;
  • FIG. 16B is an unsectioned bottom view of the enlarged plastic plug of FIG. 16A ;
  • FIG. 17A is a side view of the moveable plastic plug of FIG. 16B ;
  • FIG. 17B is a top view of the enlarged plastic plug of FIG. 17A ;
  • FIG. 18A is a full scale top view of the resilient seal plug for single and multiple use vials of FIGS. 11A, 11B and 12 A;
  • FIG. 18B is a full scale side view of the seal plug of FIG. 18A ;
  • FIG. 19A is an enlarged top view of the seal plug of FIG. 18A ;
  • FIG. 19B is an enlarge side view of the seal plug of FIG. 18B
  • FIG. 19C is a sectional view, taken along the lines 19 C- 19 C of FIG. 18A ;
  • FIG. 20A is a full scale side view of an alternative seal plug in accordance with the invention.
  • FIG. 20B is a full scale top view of the alternative seal plug of FIG. 20A
  • FIG. 20A is an enlarged top view of the seal plug of FIG. 20B ;
  • FIG. 20B is an enlarged side view of the seal plug of FIG. 20A ;
  • FIG. 20C is a sectional view, taken along the lines 20 C- 20 C of FIG. 20B ,
  • FIG. 20D is a sectional view, taken along the lines 20 D- 20 D of FIG. 20A .
  • the invention makes use of a stopper 20 and a plug 30 in the stopper 20 .
  • the syringe such as the syringe 40 of FIG. 4A , may be of any commercially available type, including the Luer-lock type shown in the Figures.
  • stopper 20 It is the combination of the stopper 20 and the plug 30 that permits the needleless transfer of medication with reduced danger of pathogen and other contamination.
  • the medicinal container 10 includes a bottle 12 with a top mouth portion 13 encircled by a flange 14 and sealed by a cover 15 that is instructed in FIG. 1B to be “flipped up” at a corner 16 and torn to expose the flange rim 17 of FIG. 1C , which shows the stopper 20 in snug fit within mouth portion 13 of the bottle 12 .
  • the stopper 20 may include a rib 21 , or the like, to improve the seal.
  • the flange 14 overlies the top edge 18 of bottle 12 .
  • the stopper 20 may be of an elastomeric, rubber-like material or a hard, self-lubricating plastic such as Teflon material.
  • the stopper 20 has a throughbore 22 , which extends from an entry portion 23 to an exit portion or opening 24 .
  • the outer surface 33 of the plug 30 Aligned with the entry position 23 of the stopper 20 is the outer surface 33 of the plug 30 .
  • a neck 25 of the stopper 20 Surrounding the plug 30 is a neck 25 of the stopper 20 .
  • the neck 25 is surrounded by a recess 26 below the entry position 23 .
  • the neck 24 can have Luer threads 27 in the recess 26 .
  • the bore 22 of the stopper 20 has side channels 28 - 1 through 28 - 4 , with the channel 26 - 2 having a bottom opening 28 - 0 in the side wall 29 , as shown in FIG. 2D .
  • the plug 30 has an upper surface 31 with protrusions 32 - 1 through 32 - 4 in order to space the tip of an inserted fitment, as discussed below, from the surface 31 in order to allow fluid flow form the fitment to the surface 31 .
  • the plug 30 also has longitudinal groove 33 in the side wall 34 .
  • FIG. 4A which is an enlarged, partial sectional view of the container of FIG. 1C
  • a Luer fitment in the form of a syringe 40 has its tip 41 brought near the surface 31 of the plug 30 , preparatory to activation.
  • the syringe 40 has its blunt tubular leading end tip 41 surrounded by a Luer threaded housing 42 , includes a plunger (not shown) and is calibrated with indicia which permit a proper dosage of medication to be withdrawn into the barrel 43 of the syringe 40 .
  • blunt end 41 is inserted against the plug 30 and into the bore 21 with the plunger extended.
  • air is injected into the container 10 to pressurize contained fluid and facilitate its withdrawal.
  • the plunger can be drawn out of the barrel 43 of the syringe 40 to the position appropriate for a desired dosage.
  • blunt nose end 44 is an interference fit between blunt nose end 44 and the bore 22 to effectively grip the syringe in the stopper during medication transfer to minimize spillage.
  • the alternative medicinal container 100 includes a bottle 120 with a top mouth portion 130 encircled by a flange 140 and sealed by a cover 150 that is instructed in FIG. 5B to be “flipped up” at a corner 16 and torn to expose the flange rim 170 of FIG. 5C , which shows the stopper 200 in snug fit within mouth portion 130 of the bottle 120 .
  • the stopper 200 may include a rib 210 , or the like, to improve the seal.
  • the flange 140 overlies the top edge 180 of bottle 120 .
  • the stopper 200 may be of an elastomeric, rubber-like material or a hard, self-lubricating plastic such as Teflon material
  • the stopper 200 has a throughbore 220 , which extends from an entry portion 230 to an exit portion or opening 240 .
  • the outer surface 330 of the plug 300 Aligned with the entry portion 230 of the stopper 200 is the outer surface 330 of the plug 300 .
  • a neck 250 of the stopper 200 to which the stopper 200 is frangibly connected Surrounding the plug 300 is a neck 250 of the stopper 200 to which the stopper 200 is frangibly connected.
  • the neck 250 is surrounded by a recess 260 below the entry position 230 .
  • the bore 220 of the stopper 200 has side channels 280 - 1 and 280 - 2 in the side wall 290 , as shown in FIG. 6E .
  • the plug 300 has an upper surface 310 with protrusions 320 - 1 through 320 - 4 in order to space the tip of an inserted fitment, as discussed below, from the surface 310 in order to allow fluid flow from the fitment to the surface 310 .
  • the plug 300 is attached to the stopper 200 by a circumferential frangible connection 311 .
  • FIG. 7A which is an enlarged, partial sectional view of the container of FIG. 5C , after removal of the cap 150 , a Luer fitment in the form of a syringe 400 has its tip 410 brought near the surface 310 of the plug 300 , preparatory to activation.
  • the syringe 400 has its blunt tubular leading end tip 410 surrounded by a Luer threaded housing 420 , includes a plunger (not shown) and is calibrated with indicia which permits a proper dosage of medication to be withdrawn into the barrel 430 of the syringe 400 .
  • blunt end 410 is inserted against the plug 300 and into the bore 210 with the plunger extended.
  • air is injected into the container 100 to pressurize contained fluid and facilitate its withdrawal.
  • the plunger can be drawn out of the barrel 430 of the syringe to the position appropriate for a desired dosage.
  • blunt nose end 440 and the bore 220 are interference fit between blunt nose end 440 and the bore 220 to effectively grip the syringe in the stopper during medication transfer to minimize spillage.
  • FIG. 8A is a partial sectional view of the container of FIG. 1C during activation by a cannula 40 ′
  • FIG. 8B is a partial sectional view of the container of FIG. 1C during activation by a Luer fitment 40 .
  • FIG. 8C is a partial sectional view of the container of FIG. 5C during activation by a cannula 400 ′
  • FIG. 8D is a partial sectional view of the container of FIG. 5C during activation by a Luer fitment 400 .
  • FIG. 9A is an enlarged, partial sectional view of another alternative embodiment of the invention preparatory to activation by a Luer fitment.
  • the three basic components for the needleless transfer of medication between the container 500 and a needleless syringe 40 in FIG. 9A include the syringe 40 , a stopper 600 and a plug 700 for the stopper 600 .
  • stopper 600 It is the combination of the stopper 600 and the plug 700 that permits the needleless transfer of medication with reduced danger of pathogen and other contamination.
  • the medicinal container 500 includes a bottle 512 with a top mouth portion 513 encircled by a flange 514 and sealed by a cover that has been torn away to expose the flange rim 517 , with the stopper 600 in snug fit within mouth portion 513 of the bottle 512 .
  • the plug 700 in the stopper 600 includes a flange 721 , or the like, to fix the position of the plug 700 on the ledge 621 of the stopper 600 .
  • the stopper 600 may be of an elastomeric, rubber-like material or a hard, self-lubricating plastic such as Teflon material.
  • the stopper 600 has a throughbore 622 , which extends from an entry portion to an exit portion or opening.
  • the outer surface 73 of the plug 700 Aligned with the entry position of the stopper 600 is the outer surface 73 of the plug 700 .
  • a neck 625 of the stopper 600 Surrounding the plug 700 is a neck 625 of the stopper 600 .
  • the neck 625 is surrounded by a recess 626 below the entry position.
  • the neck 625 can have Luer threads (not shown).
  • the bore 622 of the stopper 600 has side channels 627 - 1 and 627 - 2 , and the side wall 629 is connected from side-to-side with outlets 628 - 1 through 628 - 4 as shown in FIG. 9C .
  • the plug 700 has an upper surface 731 with protrusions 732 - 1 through 732 - 4 in order to space the tip of an inserted fitment, as discussed below, from the surface 731 in order to allow fluid flow from the fitment to the surface 731 .
  • the plug 700 also has lateral ledge 721 in the side wall 734 .
  • FIG. 9B which is a sectional view of the container 500 after cap removal, a Luer fitment in the form of a syringe 40 has its tip 41 brought near the surface 731 of the plug 700 , preparatory to activation.
  • the syringe 40 has its blunt tubular leading end tip 41 surrounded by a Luer threaded housing 42 , includes a plunger (not shown) and is calibrated with indicia which permit a proper dosage of medication to be withdrawn into the barrel 43 of the syringe 40 .
  • blunt end 41 is inserted against the plug 700 and into the bore with the plunger extended.
  • air is injected into the container 500 to pressurize contained fluid and facilitate its withdrawal
  • the plunger can be drawn out of the barrel 43 of the syringe 40 to the position appropriate for a desired dosage.
  • blunt nose end 44 and the bore 622 are an interference fit between blunt nose end 44 and the bore 622 to effectively grip the syringe in the stopper during medication transfer to minimize spillage.
  • the flange 721 becomes disengaged from the ledge 621 , and the plug is retained by the elastically expanded side wall 629 .
  • the plug 700 returns to the configuration of FIG. 9A .
  • FIG. 10A is an enlarged, partial sectional view of a further alternative embodiment of the invention preparatory to activation by a Luer fitment.
  • the three basic components for the needleless transfer of medication between the container 1000 and a needleless syringe 40 in FIG. 9A include the syringe 40 , a stopper 1600 and a plug 1700 for the stopper 1600
  • stopper 1600 It is the combination of the stopper 1600 and the plug 1700 that permits the needleless transfer of medication with reduced danger of pathogen and other contamination.
  • the medicinal container 1000 includes a bottle 1512 with a top mouth portion 1513 encircled by a flange 1514 and sealed by a cover that is torn away to expose the flange rim 1517 , with the stopper 1600 in snug fit within mouth portion 1513 of the bottle 1512 .
  • the plug 1700 in the stopper 1600 includes an intermediate rim 1721 , or the like, to fix the position of the plug 1700 against the indent 1621 of the stopper 1600 .
  • the stopper 1600 has a throughbore 1622 , which extends from an entry portion to an exit portion or opening. Aligned with the entry portion of the stopper 1600 is the outer surface 1731 of the plug 1700 . Surrounding the plug 1700 is a neck 1625 of the stopper 1600 . The neck 1625 is surrounded by a recess 1626 below the entry position. The neck 1625 can have Luer threads (not shown).
  • the side wall 1629 is connected from side-to-side with outlets 1628 - 1 through 1628 - 4 as shown in FIG. 9C .
  • the plug 1700 has an upper surface 1731 with protrusions, of which protrusions 1732 - 1 through 1732 - 3 are visible in FIGS. 10A and 10B in order to space the tip of an inserted fitment, as discussed below, from the surface 1731 in order to allow fluid flow from the fitment to the surface 1731 .
  • the flange 1721 becomes disengaged from the ledge 1621 , and the plug is retained by the elastically expanded side wall 1629 .
  • the plug 1700 returns to the configuration of FIG. 10A .
  • FIG. 11A An alternative, single-use vial 100 ′ in accordance with the invention, in partial sectional view, is shown in FIG. 11A .
  • the medicinal container 100 ′ includes a bottle 120 with a top mouth portion 130 encircled by a flange 140
  • the cover seal 15 of FIGS. 1A-1C has been omitted in FIG. 11A , and the flange rim 170 is exposed surrounding a stopper 1200 in snug fit within the mouth portion 130 of the bottle 120
  • the stopper 1200 may include an external ring 1213 , or the like, that engages the interior wall 122 of the bottle 120 below the rim 121 to improve the seal.
  • the flange 140 overlies the top edge 180 of bottle 120 .
  • the stopper 1200 may be of an elastomeric, rubber-like material or a hard, self-lubricating plastic such as Teflon material.
  • the stopper 1200 has a throughbore 1222 , which extends from an entry portion 1223 to an exit portion or opening 1224 .
  • a plug 1300 Aligned with the entry position 1223 of the stopper 1200 is the outer surface 1333 of a plug 1300 Surrounding the plug 1300 is an engagement neck 1225 of the stopper 1200 . Further engagement of the plug 1300 with the stopper 1200 is by ribs 1301 of the plug 1300 .
  • FIGS. 16A through 19C Details of the plug 1300 are shown in FIGS. 16A through 19C .
  • FIG. 11B Use of the single-use vial of FIG. 11A is illustrated in the partial sectional view of FIG. 11B .
  • a Luer fitment in the form of a syringe 40 has its tip 41 brought near the surface 31 of the plug 1300 , preparatory to activation.
  • the syringe 40 has its blunt tubular leading end tip 41 surrounded by a Luer threaded housing 42 , includes a plunger (not shown) and is calibrated with indicia which permit a proper dosage of medication to be withdrawn into the barrel 43 of the syringe 40 .
  • the tip 41 When the tip 41 is brought into contact with the plug 1300 , it is depressed into the bore 1222 and fluid can be exchanged between the syringe and the container 100 ′. The flow is from the bore of the syringe through channels between the plug 1300 and the stopper 1200 .
  • FIGS. 11 a and 11 B illustrate single-use vial access. However, the invention also provides multiple vial access as illustrated in the partial sectional view of FIG. 12A . Multi-use is achieved by employing a multi-use lock connector 1300 ′ in place of the plug 1300 .
  • the multi-lock connector 1300 ′ is discussed in detail below.
  • the vial 120 When the vial 120 is provided with a plug 1300 , it is pushed into the vial as illustrated in FIG. 11C .
  • the lock connector 1300 ′ pushes the plug 1300 into the vial 120 .
  • Other techniques can be used for pushing the plug 1300 into the vial 120 before introducing the lock connector 1300 ′.
  • the lock connector 1300 ′ is secured in the stopper 1200 by having its detent ring 1310 engage the external ring 1213 of the stopper 1200 .
  • the syringe 43 is brought into contact with the corrugated inner plug 1370 and locked on Luer threads 1352 of the housing 1350 of the lock connector 1300 ′.
  • the sectional view of the lock connector 1300 ′ for the multiple-use vial 120 of FIG. 12A is formed by the inner plug 1370 which has a head 1371 containing a slot 1373 below a depression 1372 in the head, which extends to side walls 1373 by a corrugated extension 1374 to an end 1375 .
  • the inner plug 1370 is surrounded by an upper housing 1350 which is joined to a lower housing 1360 at a recess 1366 , which accommodate a side wall 1354 of the upper housing 1350 .
  • the upper housing 1350 includes a Luer thread 1352 .
  • the head 1371 engages an internal collar 1353 of the upper housing 1350 .
  • the inner plug 1370 When the inner plug 1370 is depressed, for example, by the tip of a Luer fitment, the inner plug 1370 is depressed into the bore 1365 with the slot 1373 continuing in a closed position until the head 1371 passes from an upper collar 1361 , which has substantially the same inner diameter as the internal collar 1353 of the upper housing 1350 , to a lower collar 1362 , which has a reduced inner diameter so that further depression of the inner plug 1370 opens the slit 1373 and allows fluid passage from a Luer fitment through the inner plug 1370 out of its lower end 1375 .
  • FIG. 13A A full scale top view of the lock connector 1300 ′ is shown in FIG. 13A , and a full scale side view is shown in FIG. 13B .
  • FIG. 14A An enlarged top view of the lock connector 1300 ′ of FIG. 13B is shown in FIG. 14A and, a sectional view, taken along the lines 14 B- 14 B of FIG. 14A , is shown in FIG. 14B .
  • the slit 1373 is in a perpendicular position corresponding to the position shown in the full scale presentation of FIG. 13A .
  • FIG. 15A is an alternative top view of the lock connector 1300 ′ of FIG. 14A , after rotation through 90 degrees
  • FIG. 15B is a sectional view, taken along the lines 15 B- 15 B of FIGS. 14A and 15B , of the lock connector 1300 ′ of FIGS. 14A and 15A . Consequently, the slit 1373 occupies a horizontal position that is 90° displaced with respect to FIG. 15A .
  • FIG. 16A shows an enlarged sectional view of the moveable plastic plug 1300 of FIGS. 11A, 11B and 12 A.
  • the plug 1300 has an upper surface 1331 with ribs 1301 - 1 through 1301 - 4 in order to provide a suitable seal in relation to the inner wall of the stopper 1200 .
  • the top surface includes a depression 1302 in order to facilitate flow from an engaging Luer tip from the depression 1302 between the ribs 1301 through into the vial 120 .
  • FIG. 16B is an unsectioned bottom view of the enlarged plastic plug 1300 of FIG. 16A ;
  • FIG. 17A is a side view of the moveable plastic plug 1300 of FIG. 16B ;
  • FIG. 17B is a top view of the enlarged plastic plug 1300 of FIG. 17A .
  • the plug 1300 was fabricated of medical grade polypropylene.
  • FIG. 18A is a full scale top view of the resilient stopper 1200 for single and multiple use vials of FIGS. 11A, 11B and 12 A
  • FIG. 18B is a full scale side view of the resilient stopper 1200 of FIG. 18A .
  • FIG. 19A which is an enlarged top view of the resilient stopper 1200 of FIG. 18A , a collar 1215 surrounds a bore 1202 which includes an internal ring 1210 for secure engagement with the plug inserted into the stopper 1200 .
  • FIG. 19B which is an enlarged side view of the stopper 1200 of FIG. 18B
  • an external ring 1213 is provided to achieve secure engagement with the vial 120 into which the stopper is inserted.
  • FIG. 19C which is a sectional view, taken along the lines 19 C- 19 C of FIG. 18A .
  • the stopper 1200 was fabricated from bromobutyl compound FM257/2 with a durometer (Shore hardness of 50 ⁇ 5).
  • FIG. 20A which is a full scale side view of an alternative stopper 1200 ′ in accordance with the invention
  • an external ring 1253 is provided for enhanced engagement with the vial and a slot 1254 facilitates insertion of the alternative stopper 1200 ′ for needle access.
  • FIG. 20B is a full scale top view of FIG. 20A .
  • FIG. 20C is an enlarged side view of the alternative stopper 1200 ′ of FIG. 20A shown in section in FIG. 20C , taken along the lines 20 C- 20 C of FIG. 20B , and in FIG. 20D , taken along the lines 20 D- 20 D of FIG. 20A .

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

The invention provides for a cleansable, i.e., swabbable, access pot, formed by a stopper having a bore extending from an entry position to an exit position; and a plug in the bore at the entry position and movable in the bore; whereby the location of the plug at the entry position of the stopper permits the cleansing or swabbing of the outer surfaces of the plug and the stopper before the plug is depressed into the bore of the stopper for a vial or container in order to reduce the danger of contamination of the bore by pathogens. To convert from single-use vial access, to multiple-use vial access, the plug is replaced by a swabbable, needleless, multiple-use lock connector in which the plug contains a slit that is closed upon initial depression but is thereafter openable to permit flow through the connector into a vial or container.

Description

    FIELD OF THE INVENTION
  • This is a continuation-in-part of Ser. No. 09/073,022, filed May 4, 1998. The invention relates to coupling systems for the transfer of materials from one unit to another, and, more particularly, to coupling units with a first unit including a swabbable access port and a second unit including a blunt cannula. The access port receives the blunt cannula to effect a coupling of particular medicinal applicability for medications and body fluids. The swabbability of the access port allows disinfectant treatment before receipt of the blunt cunnula to limit the extent to which pathogens can enter the cannula after coupling is effected.
  • BACKGROUND OF THE INVENTION
  • In medical practice, containers for medication typically are bottles capped with rubber-like stoppers. A tamper-evident seal surrounds the stopper and at least the upper portion of the container. To administer medication, the seal is removed, a syringe with a needle or cannula is used to puncture the rubber stopper and withdraw a proper dosage for administration to a patient.
  • The need for a needle of cannula presents a potential hazard, both to medical personnel and to the patient. There is significant risk of infection by blood-transmitted diseases, AIDS and hepatitis from needle sticks.
  • Accordingly, it is an object of the invention to reduce the hazards associated with the administration of medication. A related object is to reduce the hazards associated with removal of medication from sealed containers.
  • In addition to medicinal containers, pointed needles or cannulae have been widely used in conjunction with other forms of access ports, which take the form of a septum or pierceable membrane. An illustrative access port that is used with a pierceable cannula is disclosed in Zdeb U.S. Pat. 4,412,573 “Injection Site” assigned to Baxter International Inc. of Deerfield, Ill.
  • The pointed cannula can be forced through the septum in order to establish fluid communication between the cannula and the container housing a medicinal substance. Access ports that are pierced by a cannula can be physically damaged by repetitive piercings and produce coring or laceration of the access port, which can result in leakage.
  • For standard drug vials, the access ports take the form of rubber stoppers which are routinely entered using conventional hypodermic needles. In order to maintain sterility, the stopper is swabbed with a disinfectant before there is a needle entry. After repeated entries, the stopper can leak because of coring and no longer function as a swabbable sterile barrier.
  • In addition to pathogens which may become present in the pierced sites, particulate matter can be generated and injected into a patient, along with pathogens. Alternatively, the pathogens and particulate matter may contaminate the contents of the vial. These conditions are pronounced with vials that are accessed multiple times.
  • Moreover, pointed cannulae used with drug vials pose a health risk to their users because of problems associated with infectious agents. Despite the fact that personnel using pointed cannulae do so with great care, from time to time accidents occur, and the users are jabbed or suffer needle sticks. Used needles also present a risk of injury and handling problems for health care facility maintenance and waste removal personnel.
  • In an attempt to overcome difficulties associated with the use of pointed cannulae, “dispensing pins” can be used to penetrate the site or stopper of multiple dose vials. A dispensing pin typically takes the shape of a sharp spike and can be used with a check valve to limit fluid leakage. One end of the spike has standard Luer fitment that is typically closed off, when not in use, by a cap. Dispensing pins tend to disengage from the vial stopper with resultant leakage. Further, it is difficult to maintain sterile conditions on this kind of multiple dose system.
  • On attempted solution has been to eliminate sharp cannulae and use blunt cannulae instead. An example is Garrett et al. U.S. Pat. 4,197,848 “Closed Urinary Irrigation Site”, assigned to Baxter International. In Garrett the injection site is a relatively thin, molded sealing member that has an opening, which permits a blunt cannula to be forced through the sealing member into fluid communication with the interior of the injection site.
  • Injection sites used with a blunt cannula have the advantage that the cannula will not pierce the skin of a user, but the pre-slit injection site has to reseal with enough force that fluids do not ooze outwardly and not allow airborne particulate matter, bacterial or viral, to enter.
  • One procedure providing for the use of a needleless syringe is disclosed in Brony, U.S. Pat. No. 5,620,434, which issued Apr. 15, 1997. Unfortunately, the open end of the valve in Brony is below the inlet of the stopper so that germs can collect on the inside wall of the stopper and not be cleansed. As a result, the use of the vial in Brony can be accompanied by dangerous pathogens.
  • Hence, there continues to be a need for an injection site, which can be used with a variety of solutions and over a range of fluid pressures. Further, there continues to be a need for such an injection site, which will reliably reseal even after many insertions of a blunt cannula and reduces the danger of contamination by dangerous pathogens.
  • If intended to be reusable, the injection site should be able to receive a large number of insertions of the cannula without displaying reseal failure Such an injection site should provide for alignment of the cannula on insertion to result in less chance of damage to the injection site after repeated insertions. In addition, although pointed cannulae desirably are to be avoided, in some situations they may be the only ones available, so that the injection site also should be usable with pointed cannulae.
  • Further, the injection site should be usable with a blunt cannula with a reasonable level of insertion force that will permit health care personnel to readily insert the cannula, but yet not have the cannula easily displaced after insertion.
  • On attempt to meet these objectives is disclosed in Dudar et al. U.S. Ser. No. 425,790 (Oct. 23, 1989) “Pre-Slit Injection Site” in which one end of a housing carries a pre-slit septum, and a second end has a coupling to adapt the housing to standard vials. The coupling or a vial adapter includes a spike with opening that allows drainage of fluid in the vial through the spike and into the injection site. The vial adapter has a skirt, which protects the adapter spike in both manufacture and use. The skirt also permits locking engagement of the adapter with injection site to standard vials, despite dimensional variations in vial closures The coupling spike can have a barb that can be inserted into a standard vial and resist disengagement. A blunt cannula is used with the combination of the injection site with the coupling. This system is both complex and cumbersome.
  • Accordingly, it is a further object of the invention to achieve the foregoing advantages without the need for a pre-slit injection site.
  • SUMMARY OF THE INVENTION
  • In accomplishing the foregoing and related objectives, the invention provides for a cleansable, i.e., swabbable, access port, formed by a stopper having a bore extending from an entry position to an exit position; and a plug in the bore at the entry position and movable in the bore; whereby the location of the plug at the entry position of the stopper permits the cleansing or swabbing of the outer surfaces of the plug and the stopper before the plug is depressed into the bore of the stopper in order to reduce the danger of contamination of the bore by pathogens.
  • In accordance with one aspect of the invention, the swabbable plug extends integrally across the bore and can be frangibly connected to the bore, or be slidably connected to the bore.
  • In accordance with another aspect of the invention the swabbable plug has a non-planar external surface and is pierceable by a cannula or needle. The stopper can have a collar at the entry position, and the collar can have external Luer threads.
  • A stretchable and apertured membrane can span the exit position of the bore so that when the plug is depressed into the bore by, for example the end of a fitment, the plug can be restored to its original, swabbable position at the entry position of the stopper when the fitment is removed.
  • In accordance with a method of the invention for accessing a port, the steps include (a) swabbing or cleansing a movable plug positioned in the bore of a stopper, for which the bore extends from an entry position, where the plug is swabbed, to an exit position; and (b) moving the plug within the bore away from the entry position; whereby communication can be established along the bore between the entry position and the exit position.
  • The method further includes the step of swabbing an integral surface of the movable plug, with the surface extending integrally across the bore. The swabbing can be with respect to frangible connections to the bore.
  • In one aspect of the method, further steps include slidably moving the plug along the bore; engaging the plug by a fitment with a transverse gap between a portion of the exterior surface of the plug and the engagement end of the fitment; and piercing the plug by a cannula.
  • In another aspect of the method, the steps include engaging a collar of the stopper at the entry position of the bore; engaging external Luer threads of the collar; stretching an apertured membrane that spans the exit position of the bore; and causing fluid to flow in an auxiliary channel of the bore when the plug is depressed in the bore.
  • A system of the invention for the transfer of medication from a container includes (a) a needleless syringe having a blunt tubular end; (b) a stopper positioned in a neck portion of the container and having a central throughbore extending from an outer surface of the stopper to the interior of the container; (c) a plug extending into the bore from the outer surface of the stopper; (d) protrusions on the plug for engagement by the end of the syringe permitting fluid flow between the syringe and the plug; and (e) an auxiliary channel in the bore permitting the fluid flow to extend between the container and the syringe.
  • The invention enables the needleless and disinfected transfer of medication using a stopper with a movable plug having an integral surface for engagement of the plug by a fitment, such as the Luer end of a syringe. By using the invention, medication can be withdrawn from a container with or without the use of a needle, after disinfectant treatment of the engagement surface of the plug to remove pathogens and possible contaminants.
  • In accordance with still another aspect of the invention, single use vial or container access is transformed to multi-use vial or container access by replacing a single-use access plug with a swabbable, needleless, multiple-use lock connector.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Various other features, advantages and characteristics of the invention will become apparent after considering several illustrative embodiments, taken in conjunction with the drawings, in which:
  • FIG. 1A is a plan view of a stoppered medicinal container in accordance with the invention;
  • FIG. 1B is a top view of the stoppered medicinal container of FIG. 1A;
  • FIG. 1C is a partial sectional view of the stoppered medicinal container of FIG. 1A;
  • FIG. 2A is a full-scale side view of the stopper and plug of the medicinal container of FIG. 1A;
  • FIG. 2B is a full-scale top view of the stopper and plug of the medicinal container of FIG. 1A;
  • FIG. 2C is an enlarged sectional view of the stopper of the medicinal container of FIG. 1A;
  • FIG. 2D is a partial top view of the stopper of FIG. 2C;
  • FIG. 2D is a partial bottom view of the stopper of FIG. 2C;
  • FIG. 2F is an enlarged, partial sectional view of an alternative stopper collar portion of the invention;
  • FIG. 2G is an enlarged sectional view of an alternative stopper for the container of FIG. 1C:
  • FIG. 3A is a full-scale side view of the plug of the stopper of FIG. 2A;
  • FIG. 3B is a full-scale top view of the plug of the stopper of FIG. 2A;
  • FIG. 3C is an enlarged view of the plug of FIG. 3A:
  • FIG. 3D is an enlarged view of the plug of FIG. 3B;
  • FIG. 3E is a sectional view of the plug of FIG. 3C:
  • FIG. 4A is an enlarged, partial sectional view of the container of FIG. 1C preparatory to activation by a Luer fitment;
  • FIG. 4B is an enlarged, partial sectional view of the container of FIG. 1C during activation by a Luer fitment;
  • FIG. 5A is a plan view of an alternative, stoppered medicinal container in accordance with the invention;
  • FIG. 5B is top view of the stoppered medicinal container of FIG. 5A;
  • FIG. 5C is a partial sectional view of the stoppered medicinal container of FIG. 5A;
  • FIG. 6A is a full-scale side view of the stopper and plug of the medicinal container of FIG. 5A:
  • FIG. 6B is a full-scale top view of the stopper and plug of the medicinal container of FIG. 5A;
  • FIG. 6C is an enlarged sectional view of the stopper and plug of the medicinal container of FIG. 5A;
  • FIG. 6D is a partial top view of the stopper and plug of FIG. 6C;
  • FIG. 6E is a partial bottom view of the stopper of FIG. 6C;
  • FIG. 6F is an enlarged, partial sectional view showing the alternative stopper for the container of FIG. 5C;
  • FIG. 7A is an enlarged, partial sectional view of the container of FIG. 5C preparatory to activation by a Luer fitment;
  • FIG. 7B is an enlarged, partial sectional view of the container of FIG. 5C during activation by a Luer fitment;
  • FIG. 8A is a partial sectional view of the container of FIG. 1C during activation by a cannula;
  • FIG. 8B is a partial sectional view of the container of FIG. 1C during activation by a Luer fitment;
  • FIG. 8C is a partial sectional view of the container of FIG. 5C during activation by a cannula;
  • FIG. 8D is a partial sectional view of the container of FIG. 5C during activation by a Luer fitment;
  • FIG. 9A is an enlarged, partial sectional view of another alternative embodiment of the invention preparatory to activation by a Luer fitment;
  • FIG. 9B is an enlarged, partial sectional view of another alternative embodiment of the invention during activation by a Luer fitment;
  • FIG. 9C is a partial sectional view of the bottom of the stopper and plug combination of FIGS. 9A and 9B;
  • FIG. 10A is an enlarged, partial sectional view of still another alternative embodiment of the invention preparatory to activation by a Luer fitment;
  • FIG. 10B is an enlarged, partial sectional view of another alternative embodiment of the invention during activation by a Luer fitment;
  • FIG. 10C is a partial sectional view of the bottom of the stopper and plug combination of FIG. 10A;
  • FIG. 11A is a partial sectional view of an alternative, single-use vial in accordance with the invention
  • FIG. 11B is a partial sectional view illustrating use of the single-use vial of FIG. 11A;
  • FIG. 12A is a partial sectional view of an alternative, multiple-use vial in use in accordance with the invention;
  • FIG. 12B a sectional view of the central adapter for the multiple-use vial of FIG. 12A;
  • FIG. 13A is a full scale top view of the central adapter of FIG. 12B;
  • FIG. 13B is a full scale side view of the central adapter of FIG. 13A;
  • FIG. 14A is an enlarged top view of the central adapter of FIG. 12B
  • FIG. 14B is a sectional view, taken along the lines 14B-14B of FIG. 14A, of the central adapter of FIG. 14A;
  • FIG. 15A is an alternative view of the central adapter of FIG. 14A, after rotation through 90 degrees;
  • FIG. 15B is a sectional view, taken along the lines 15B-15B of FIGS. 14A and 15B, of the central adapter of FIGS. 14A and 15A;
  • FIG. 16A is an enlarged sectional view of the moveable plastic plug of FIGS. 11A, 11B and 12A;
  • FIG. 16B is an unsectioned bottom view of the enlarged plastic plug of FIG. 16A;
  • FIG. 17A is a side view of the moveable plastic plug of FIG. 16B;
  • FIG. 17B is a top view of the enlarged plastic plug of FIG. 17A;
  • FIG. 18A is a full scale top view of the resilient seal plug for single and multiple use vials of FIGS. 11A, 11B and 12A;
  • FIG. 18B is a full scale side view of the seal plug of FIG. 18A;
  • FIG. 19A is an enlarged top view of the seal plug of FIG. 18A;
  • FIG. 19B is an enlarge side view of the seal plug of FIG. 18B
  • FIG. 19C is a sectional view, taken along the lines 19C-19C of FIG. 18A;
  • FIG. 20A is a full scale side view of an alternative seal plug in accordance with the invention;
  • FIG. 20B is a full scale top view of the alternative seal plug of FIG. 20A
  • FIG. 20A is an enlarged top view of the seal plug of FIG. 20B;
  • FIG. 20B is an enlarged side view of the seal plug of FIG. 20A;
  • FIG. 20C is a sectional view, taken along the lines 20C-20C of FIG. 20B,
  • FIG. 20D is a sectional view, taken along the lines 20D-20D of FIG. 20A.
  • DETAILED DESCRIPTION
  • As shown in the Figures, there are three basic components for the needleless transfer of medication between a container 10 and a syringe. Besides the syringe, which may be needleless, the invention makes use of a stopper 20 and a plug 30 in the stopper 20.
  • The syringe, such as the syringe 40 of FIG. 4A, may be of any commercially available type, including the Luer-lock type shown in the Figures.
  • It is the combination of the stopper 20 and the plug 30 that permits the needleless transfer of medication with reduced danger of pathogen and other contamination.
  • As shown in FIG. 1A, the medicinal container 10 includes a bottle 12 with a top mouth portion 13 encircled by a flange 14 and sealed by a cover 15 that is instructed in FIG. 1B to be “flipped up” at a corner 16 and torn to expose the flange rim 17 of FIG. 1C, which shows the stopper 20 in snug fit within mouth portion 13 of the bottle 12. The stopper 20 may include a rib 21, or the like, to improve the seal. The flange 14 overlies the top edge 18 of bottle 12.
  • The stopper 20 may be of an elastomeric, rubber-like material or a hard, self-lubricating plastic such as Teflon material. The stopper 20 has a throughbore 22, which extends from an entry portion 23 to an exit portion or opening 24.
  • Aligned with the entry position 23 of the stopper 20 is the outer surface 33 of the plug 30. Surrounding the plug 30 is a neck 25 of the stopper 20. In FIG. 1C the neck the neck 25 is surrounded by a recess 26 below the entry position 23. As indicated in FIG. 2F, the neck 24 can have Luer threads 27 in the recess 26.
  • As more clearly shown in FIGS. 2C and 2E, the bore 22 of the stopper 20 has side channels 28-1 through 28-4, with the channel 26-2 having a bottom opening 28-0 in the side wall 29, as shown in FIG. 2D.
  • Details of the plug 30 are shown in FIGS. 3C through 3F. The plug 30 has an upper surface 31 with protrusions 32-1 through 32-4 in order to space the tip of an inserted fitment, as discussed below, from the surface 31 in order to allow fluid flow form the fitment to the surface 31. The plug 30 also has longitudinal groove 33 in the side wall 34.
  • As shown in FIG. 4A, which is an enlarged, partial sectional view of the container of FIG. 1C, after removal of the cap 15, a Luer fitment in the form of a syringe 40 has its tip 41 brought near the surface 31 of the plug 30, preparatory to activation. The syringe 40 has its blunt tubular leading end tip 41 surrounded by a Luer threaded housing 42, includes a plunger (not shown) and is calibrated with indicia which permit a proper dosage of medication to be withdrawn into the barrel 43 of the syringe 40.
  • As indicated in FIG. 4B, when the tip 41 is brought into contact with the protuberances 32-1 through 32-4, and the housing 42 is pushed into the groove 26, the plug 30 is depressed into the bore 22 and fluid can be exchanged between the syringe and the container. The flow is through the channels and the bore of the syringe.
  • In actual practice, blunt end 41 is inserted against the plug 30 and into the bore 21 with the plunger extended. For the withdrawal of fluid, air is injected into the container 10 to pressurize contained fluid and facilitate its withdrawal. The plunger can be drawn out of the barrel 43 of the syringe 40 to the position appropriate for a desired dosage. There is an interference fit between blunt nose end 44 and the bore 22 to effectively grip the syringe in the stopper during medication transfer to minimize spillage.
  • As shown in FIG. 5A, the alternative medicinal container 100 includes a bottle 120 with a top mouth portion 130 encircled by a flange 140 and sealed by a cover 150 that is instructed in FIG. 5B to be “flipped up” at a corner 16 and torn to expose the flange rim 170 of FIG. 5C, which shows the stopper 200 in snug fit within mouth portion 130 of the bottle 120. The stopper 200 may include a rib 210, or the like, to improve the seal. The flange 140 overlies the top edge 180 of bottle 120.
  • The stopper 200 may be of an elastomeric, rubber-like material or a hard, self-lubricating plastic such as Teflon material The stopper 200 has a throughbore 220, which extends from an entry portion 230 to an exit portion or opening 240.
  • Aligned with the entry portion 230 of the stopper 200 is the outer surface 330 of the plug 300. Surrounding the plug 300 is a neck 250 of the stopper 200 to which the stopper 200 is frangibly connected. In FIG. 5C, the neck 250 is surrounded by a recess 260 below the entry position 230.
  • As more clearly shown in FIGS. 6C and 6E, the bore 220 of the stopper 200 has side channels 280-1 and 280-2 in the side wall 290, as shown in FIG. 6E.
  • Details of the plug 300 are shown in FIGS. 6C and 6F. The plug 300 has an upper surface 310 with protrusions 320-1 through 320-4 in order to space the tip of an inserted fitment, as discussed below, from the surface 310 in order to allow fluid flow from the fitment to the surface 310. The plug 300 is attached to the stopper 200 by a circumferential frangible connection 311. As shown in FIG. 7A, which is an enlarged, partial sectional view of the container of FIG. 5C, after removal of the cap 150, a Luer fitment in the form of a syringe 400 has its tip 410 brought near the surface 310 of the plug 300, preparatory to activation.
  • The syringe 400 has its blunt tubular leading end tip 410 surrounded by a Luer threaded housing 420, includes a plunger (not shown) and is calibrated with indicia which permits a proper dosage of medication to be withdrawn into the barrel 430 of the syringe 400.
  • As indicated in FIG. 7B, when the tip 410 is brought into contact with the protuberances 320-1 through 320-4, and the housing 420 is pushed into the groove 260, the frangible connection 311 is severed and the plug 300 is depressed into the bore 200, and fluid can be exchanged between the syringe and the container. The flow is through the channels and the bore of the syringe.
  • In actual practice, blunt end 410 is inserted against the plug 300 and into the bore 210 with the plunger extended. For the withdrawal of fluid, air is injected into the container 100 to pressurize contained fluid and facilitate its withdrawal. The plunger can be drawn out of the barrel 430 of the syringe to the position appropriate for a desired dosage. There is an interference fit between blunt nose end 440 and the bore 220 to effectively grip the syringe in the stopper during medication transfer to minimize spillage.
  • FIG. 8A is a partial sectional view of the container of FIG. 1C during activation by a cannula 40′, while FIG. 8B is a partial sectional view of the container of FIG. 1C during activation by a Luer fitment 40.
  • FIG. 8C is a partial sectional view of the container of FIG. 5C during activation by a cannula 400′, while FIG. 8D is a partial sectional view of the container of FIG. 5C during activation by a Luer fitment 400.
  • FIG. 9A is an enlarged, partial sectional view of another alternative embodiment of the invention preparatory to activation by a Luer fitment. The three basic components for the needleless transfer of medication between the container 500 and a needleless syringe 40 in FIG. 9A include the syringe 40, a stopper 600 and a plug 700 for the stopper 600.
  • It is the combination of the stopper 600 and the plug 700 that permits the needleless transfer of medication with reduced danger of pathogen and other contamination.
  • As shown in FIG. 9A, the medicinal container 500 includes a bottle 512 with a top mouth portion 513 encircled by a flange 514 and sealed by a cover that has been torn away to expose the flange rim 517, with the stopper 600 in snug fit within mouth portion 513 of the bottle 512.
  • The plug 700 in the stopper 600 includes a flange 721, or the like, to fix the position of the plug 700 on the ledge 621 of the stopper 600.
  • The stopper 600 may be of an elastomeric, rubber-like material or a hard, self-lubricating plastic such as Teflon material. The stopper 600 has a throughbore 622, which extends from an entry portion to an exit portion or opening.
  • Aligned with the entry position of the stopper 600 is the outer surface 73 of the plug 700. Surrounding the plug 700 is a neck 625 of the stopper 600. The neck 625 is surrounded by a recess 626 below the entry position. The neck 625 can have Luer threads (not shown).
  • The bore 622 of the stopper 600 has side channels 627-1 and 627-2, and the side wall 629 is connected from side-to-side with outlets 628-1 through 628-4 as shown in FIG. 9C.
  • The plug 700 has an upper surface 731 with protrusions 732-1 through 732-4 in order to space the tip of an inserted fitment, as discussed below, from the surface 731 in order to allow fluid flow from the fitment to the surface 731. The plug 700 also has lateral ledge 721 in the side wall 734.
  • As shown in FIG. 9B, which is a sectional view of the container 500 after cap removal, a Luer fitment in the form of a syringe 40 has its tip 41 brought near the surface 731 of the plug 700, preparatory to activation.
  • The syringe 40 has its blunt tubular leading end tip 41 surrounded by a Luer threaded housing 42, includes a plunger (not shown) and is calibrated with indicia which permit a proper dosage of medication to be withdrawn into the barrel 43 of the syringe 40.
  • As indicated in FIG. 9B, when the tip 41 is brought into contact with the protuberances 732-1 through 732-4, and the housing 42 is pushed into the groove 626, the plug 700 is depressed into the bore 622 and fluid can be exchanged between the syringe and the container. The flow is through the channels and the bore of the syringe.
  • In actual practice, blunt end 41 is inserted against the plug 700 and into the bore with the plunger extended. For the withdrawal of fluid, air is injected into the container 500 to pressurize contained fluid and facilitate its withdrawal The plunger can be drawn out of the barrel 43 of the syringe 40 to the position appropriate for a desired dosage. There is an interference fit between blunt nose end 44 and the bore 622 to effectively grip the syringe in the stopper during medication transfer to minimize spillage.
  • As the nose end 44 is pushed into the bore 622, the flange 721 becomes disengaged from the ledge 621, and the plug is retained by the elastically expanded side wall 629. When the nose end 44 is withdrawn, the plug 700 returns to the configuration of FIG. 9A.
  • FIG. 10A is an enlarged, partial sectional view of a further alternative embodiment of the invention preparatory to activation by a Luer fitment. Again, the three basic components for the needleless transfer of medication between the container 1000 and a needleless syringe 40 in FIG. 9A include the syringe 40, a stopper 1600 and a plug 1700 for the stopper 1600
  • It is the combination of the stopper 1600 and the plug 1700 that permits the needleless transfer of medication with reduced danger of pathogen and other contamination.
  • As shown in FIG. 10A, the medicinal container 1000 includes a bottle 1512 with a top mouth portion 1513 encircled by a flange 1514 and sealed by a cover that is torn away to expose the flange rim 1517, with the stopper 1600 in snug fit within mouth portion 1513 of the bottle 1512. The plug 1700 in the stopper 1600 includes an intermediate rim 1721, or the like, to fix the position of the plug 1700 against the indent 1621 of the stopper 1600.
  • The stopper 1600 has a throughbore 1622, which extends from an entry portion to an exit portion or opening. Aligned with the entry portion of the stopper 1600 is the outer surface 1731 of the plug 1700. Surrounding the plug 1700 is a neck 1625 of the stopper 1600. The neck 1625 is surrounded by a recess 1626 below the entry position. The neck 1625 can have Luer threads (not shown).
  • The side wall 1629 is connected from side-to-side with outlets 1628-1 through 1628-4 as shown in FIG. 9C.
  • The plug 1700 has an upper surface 1731 with protrusions, of which protrusions 1732-1 through 1732-3 are visible in FIGS. 10A and 10B in order to space the tip of an inserted fitment, as discussed below, from the surface 1731 in order to allow fluid flow from the fitment to the surface 1731.
  • As indicated in FIG. 10B, when the tip 41 is brought into contact with the protuberances 1732-1 through 1732-4, and the housing 42 is pushed into the groove 1626, the plug 1700 is depressed into the bore 1622, creating side channels 1627-1 and 1627-2, and fluid can be exchanged between the syringe and the container. The flow is through the channels and the bore of the syringe.
  • As the nose end 44 is pushed into the bore 1622, the flange 1721 becomes disengaged from the ledge 1621, and the plug is retained by the elastically expanded side wall 1629. When the nose end 44 is withdrawn, the plug 1700 returns to the configuration of FIG. 10A.
  • An alternative, single-use vial 100′ in accordance with the invention, in partial sectional view, is shown in FIG. 11A. The medicinal container 100′ includes a bottle 120 with a top mouth portion 130 encircled by a flange 140 The cover seal 15 of FIGS. 1A-1C has been omitted in FIG. 11A, and the flange rim 170 is exposed surrounding a stopper 1200 in snug fit within the mouth portion 130 of the bottle 120 The stopper 1200 may include an external ring 1213, or the like, that engages the interior wall 122 of the bottle 120 below the rim 121 to improve the seal. The flange 140 overlies the top edge 180 of bottle 120.
  • The stopper 1200 may be of an elastomeric, rubber-like material or a hard, self-lubricating plastic such as Teflon material. The stopper 1200 has a throughbore 1222, which extends from an entry portion 1223 to an exit portion or opening 1224.
  • Aligned with the entry position 1223 of the stopper 1200 is the outer surface 1333 of a plug 1300 Surrounding the plug 1300 is an engagement neck 1225 of the stopper 1200. Further engagement of the plug 1300 with the stopper 1200 is by ribs 1301 of the plug 1300.
  • Details of the plug 1300 are shown in FIGS. 16A through 19C.
  • Use of the single-use vial of FIG. 11A is illustrated in the partial sectional view of FIG. 11B. As shown in FIG. 11B, a Luer fitment in the form of a syringe 40 has its tip 41 brought near the surface 31 of the plug 1300, preparatory to activation. The syringe 40 has its blunt tubular leading end tip 41 surrounded by a Luer threaded housing 42, includes a plunger (not shown) and is calibrated with indicia which permit a proper dosage of medication to be withdrawn into the barrel 43 of the syringe 40.
  • When the tip 41 is brought into contact with the plug 1300, it is depressed into the bore 1222 and fluid can be exchanged between the syringe and the container 100′. The flow is from the bore of the syringe through channels between the plug 1300 and the stopper 1200.
  • FIGS. 11 a and 11B illustrate single-use vial access. However, the invention also provides multiple vial access as illustrated in the partial sectional view of FIG. 12A. Multi-use is achieved by employing a multi-use lock connector 1300′ in place of the plug 1300. The multi-lock connector 1300′ is discussed in detail below.
  • When the vial 120 is provided with a plug 1300, it is pushed into the vial as illustrated in FIG. 11C.
  • In replacing the plug 1300, the lock connector 1300′ pushes the plug 1300 into the vial 120. Other techniques can be used for pushing the plug 1300 into the vial 120 before introducing the lock connector 1300′.
  • The lock connector 1300′ is secured in the stopper 1200 by having its detent ring 1310 engage the external ring 1213 of the stopper 1200.
  • In use, the syringe 43 is brought into contact with the corrugated inner plug 1370 and locked on Luer threads 1352 of the housing 1350 of the lock connector 1300′.
  • With reference to FIG. 12B, the sectional view of the lock connector 1300′ for the multiple-use vial 120 of FIG. 12A, is formed by the inner plug 1370 which has a head 1371 containing a slot 1373 below a depression 1372 in the head, which extends to side walls 1373 by a corrugated extension 1374 to an end 1375. The inner plug 1370 is surrounded by an upper housing 1350 which is joined to a lower housing 1360 at a recess 1366, which accommodate a side wall 1354 of the upper housing 1350. In order to accommodate a Luer fitment, the upper housing 1350 includes a Luer thread 1352. The head 1371 engages an internal collar 1353 of the upper housing 1350. When the inner plug 1370 is depressed, for example, by the tip of a Luer fitment, the inner plug 1370 is depressed into the bore 1365 with the slot 1373 continuing in a closed position until the head 1371 passes from an upper collar 1361, which has substantially the same inner diameter as the internal collar 1353 of the upper housing 1350, to a lower collar 1362, which has a reduced inner diameter so that further depression of the inner plug 1370 opens the slit 1373 and allows fluid passage from a Luer fitment through the inner plug 1370 out of its lower end 1375.
  • A full scale top view of the lock connector 1300′ is shown in FIG. 13A, and a full scale side view is shown in FIG. 13B.
  • An enlarged top view of the lock connector 1300′ of FIG. 13B is shown in FIG. 14A and, a sectional view, taken along the lines 14B-14B of FIG. 14A, is shown in FIG. 14B. In FIG. 14A, the slit 1373 is in a perpendicular position corresponding to the position shown in the full scale presentation of FIG. 13A.
  • FIG. 15A is an alternative top view of the lock connector 1300′ of FIG. 14A, after rotation through 90 degrees, and FIG. 15B is a sectional view, taken along the lines 15B-15B of FIGS. 14A and 15B, of the lock connector 1300′ of FIGS. 14A and 15A. Consequently, the slit 1373 occupies a horizontal position that is 90° displaced with respect to FIG. 15A.
  • FIG. 16A shows an enlarged sectional view of the moveable plastic plug 1300 of FIGS. 11A, 11B and 12A. The plug 1300 has an upper surface 1331 with ribs 1301-1 through 1301-4 in order to provide a suitable seal in relation to the inner wall of the stopper 1200. The top surface includes a depression 1302 in order to facilitate flow from an engaging Luer tip from the depression 1302 between the ribs 1301 through into the vial 120.
  • FIG. 16B is an unsectioned bottom view of the enlarged plastic plug 1300 of FIG. 16A; FIG. 17A is a side view of the moveable plastic plug 1300 of FIG. 16B; and FIG. 17B is a top view of the enlarged plastic plug 1300 of FIG. 17A. In a illustrative embodiment of the invention, the plug 1300 was fabricated of medical grade polypropylene.
  • FIG. 18A is a full scale top view of the resilient stopper 1200 for single and multiple use vials of FIGS. 11A, 11B and 12A, and FIG. 18B is a full scale side view of the resilient stopper 1200 of FIG. 18A.
  • As shown in FIG. 19A, which is an enlarged top view of the resilient stopper 1200 of FIG. 18A, a collar 1215 surrounds a bore 1202 which includes an internal ring 1210 for secure engagement with the plug inserted into the stopper 1200.
  • In FIG. 19B, which is an enlarged side view of the stopper 1200 of FIG. 18B, an external ring 1213 is provided to achieve secure engagement with the vial 120 into which the stopper is inserted. Both the external ring 1213 and the internal ring 1210 are further illustrated in FIG. 19C, which is a sectional view, taken along the lines 19C-19C of FIG. 18A. In an illustrative embodiment of the invention, the stopper 1200 was fabricated from bromobutyl compound FM257/2 with a durometer (Shore hardness of 50±5).
  • FIG. 20A, which is a full scale side view of an alternative stopper 1200′ in accordance with the invention, an external ring 1253 is provided for enhanced engagement with the vial and a slot 1254 facilitates insertion of the alternative stopper 1200′ for needle access. Other views of the alternative stopper 1200′ are provided by FIG. 20B, which is a full scale top view of FIG. 20A.
  • FIG. 20C is an enlarged side view of the alternative stopper 1200′ of FIG. 20A shown in section in FIG. 20C, taken along the lines 20C-20C of FIG. 20B, and in FIG. 20D, taken along the lines 20D-20D of FIG. 20A.
  • Various changes, alternatives and modifications will become apparent to a person of ordinary skill in the art following a reading of the foregoing specification. It is intended that all such changes, alternatives and modifications as fall within the scope of the appended claims be considered part of the present invention.

Claims (20)

1. A cleansable access port, comprising:
a stopper having a bore extending from an entry position to an exit position; and a plug in said bore at said entry position and movable in said bore;
whereby the location of said plug at the entry position of said stopper permits the cleansing of the outer surfaces of said plug and said stopper before said plug is depressed into said bore of said stopper in order to reduce the danger of contamination of said bore by pathogens.
2. The method of accessing a port, comprising the steps of:
(a) swabbing a plug that extends integrally across the bore of a stopper, for which said bore extends from an entry position, where said plug is swabbed, to an exit position; and
(b) moving said plug within said bore away from said entry position;
whereby communication can be established along said bore between said entry position and said exit position.
3. The method of claim 2 for accessing a port, further comprising the step of:
swabbing said movable plug with respect to frangible, breakable, connections thereof to said bore.
4. The method of claim 2 for accessing a port, further comprising the step of:
slidably moving said plug along said bore.
5. The method of claim 2 for accessing a port, further comprising:
engaging said plug by a fitment with a transverse gap between a portion of the exterior surface of said plug and the engagement end of said fitment.
6. The method of claim 1 for accessing a port further comprising the step of:
piercing to make a hole through said plug by a cannula.
7. The method of claim 1 for accessing a port, further comprising the step of:
engaging a recessed, depressed collar of said stopper at said entry position of said bore.
8. The method of claim 2 for accessing a port, further comprising the step of:
replacing said plug by a swabble, needleless multiple-use lock connector.
9. The method of claim 2 for accessing a port, further comprising the step of:
stretching an apertured membrane that spans said exit position of said bore.
10. The method of claim 2 for accessing a port, further comprising the step of:
causing fluid to flow in an auxiliary channel of said bore when said plug is depressed in said bore.
11. The method of accessing a port, comprising the steps of:
moving a plug to the entry position of a bore extending to an exit position of a port; and
engaging said plug at said entry position and slidably moving said plug through said bore.
12. The method of accessing a port as defined in claim 11 further including the step of extending said movable plug integrally across said bore to a stopper surrounding said plug.
13. The method of accessing a port as defined in claim 11 further including the step of frangibly connecting said plug to said bore.
14. The method of accessing a port as defined in claim 11 further including the step of slidably connecting said plug within said bore.
15. The method of accessing a port as defined in claim 11 further including the step of providing said plug with a non-planar external surface
16. The method of accessing a port as defined in claim 11 further including the step of piercing said plug by a cannula with said plug seated in a stopper.
17. The method of accessing a port as defined in claim 11 further including the step of providing said plug in a stopper with a recessed collar at said entry position.
18. The method of accessing a port as defined in claim 17 further including the step of providing said recessed collar with external Luer threads.
19. The method of accessing a port as defined in claim 11 further including the step of spanning said exit position of said bore with a stretchable membrane.
20. A method of transferring fluid from a container, comprising the steps of:
(a) positioning a stopper in a neck portion of a container having a central throughbore extending from an outer surface of said stopper to the interior of said container;
(b) extending a plug into said bore from an entry position at said outer surface of said stopper; and
(c) depressing said plug to permit fluid to flow between said interior and said outer surface.
US10/236,782 1998-05-04 2002-09-07 Swabbable needleless vial access Abandoned US20050055008A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/236,782 US20050055008A1 (en) 1998-05-04 2002-09-07 Swabbable needleless vial access

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/073,022 US6692478B1 (en) 1998-05-04 1998-05-04 Swabbable needleless vial access
US10/236,782 US20050055008A1 (en) 1998-05-04 2002-09-07 Swabbable needleless vial access

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/073,022 Continuation US6692478B1 (en) 1998-05-04 1998-05-04 Swabbable needleless vial access

Publications (1)

Publication Number Publication Date
US20050055008A1 true US20050055008A1 (en) 2005-03-10

Family

ID=31186046

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/073,022 Expired - Fee Related US6692478B1 (en) 1998-05-04 1998-05-04 Swabbable needleless vial access
US10/236,782 Abandoned US20050055008A1 (en) 1998-05-04 2002-09-07 Swabbable needleless vial access

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/073,022 Expired - Fee Related US6692478B1 (en) 1998-05-04 1998-05-04 Swabbable needleless vial access

Country Status (1)

Country Link
US (2) US6692478B1 (en)

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090036861A1 (en) * 2007-08-01 2009-02-05 Hospira, Inc. Medicament admixing system
US20110022023A1 (en) * 2008-01-09 2011-01-27 Novartis Ag Unitary withdrawal spike unit suitable for factory fitting
US20120265163A1 (en) * 2011-04-14 2012-10-18 Marc Bunjiun Cheng Coupling system to transfer material between containers
US20130196422A1 (en) * 2010-07-23 2013-08-01 Beckman Coulter, Inc. System and method including analytical units
US8608723B2 (en) 2009-11-12 2013-12-17 Medimop Medical Projects Ltd. Fluid transfer devices with sealing arrangement
US8684994B2 (en) 2010-02-24 2014-04-01 Medimop Medical Projects Ltd. Fluid transfer assembly with venting arrangement
US8721612B2 (en) 2010-12-17 2014-05-13 Hospira, Inc. System and method for intermixing the contents of two containers
US8752598B2 (en) 2011-04-17 2014-06-17 Medimop Medical Projects Ltd. Liquid drug transfer assembly
US8753325B2 (en) 2010-02-24 2014-06-17 Medimop Medical Projects, Ltd. Liquid drug transfer device with vented vial adapter
US8834444B2 (en) 2011-10-03 2014-09-16 Hospira, Inc. System and method for mixing the contents of two containers
US8852145B2 (en) 2010-11-14 2014-10-07 Medimop Medical Projects, Ltd. Inline liquid drug medical device having rotary flow control member
US8905994B1 (en) 2011-10-11 2014-12-09 Medimop Medical Projects, Ltd. Valve assembly for use with liquid container and drug vial
USD720451S1 (en) 2012-02-13 2014-12-30 Medimop Medical Projects Ltd. Liquid drug transfer assembly
US8979792B2 (en) 2009-11-12 2015-03-17 Medimop Medical Projects Ltd. Inline liquid drug medical devices with linear displaceable sliding flow control member
US8998875B2 (en) 2009-10-01 2015-04-07 Medimop Medical Projects Ltd. Vial assemblage with vial and pre-attached fluid transfer device
USD734868S1 (en) 2012-11-27 2015-07-21 Medimop Medical Projects Ltd. Drug vial adapter with downwardly depending stopper
USD737436S1 (en) 2012-02-13 2015-08-25 Medimop Medical Projects Ltd. Liquid drug reconstitution assembly
US9283324B2 (en) 2012-04-05 2016-03-15 Medimop Medical Projects, Ltd Fluid transfer devices having cartridge port with cartridge ejection arrangement
US9339438B2 (en) 2012-09-13 2016-05-17 Medimop Medical Projects Ltd. Telescopic female drug vial adapter
USD757933S1 (en) 2014-09-11 2016-05-31 Medimop Medical Projects Ltd. Dual vial adapter assemblage
USD765837S1 (en) 2013-08-07 2016-09-06 Medimop Medical Projects Ltd. Liquid transfer device with integral vial adapter
USD767124S1 (en) 2013-08-07 2016-09-20 Medimop Medical Projects Ltd. Liquid transfer device with integral vial adapter
US9795536B2 (en) 2012-08-26 2017-10-24 Medimop Medical Projects, Ltd. Liquid drug transfer devices employing manual rotation for dual flow communication step actuations
USD801522S1 (en) 2015-11-09 2017-10-31 Medimop Medical Projects Ltd. Fluid transfer assembly
US9801786B2 (en) 2013-04-14 2017-10-31 Medimop Medical Projects Ltd. Drug container closure for mounting on open-topped drug container to form drug reconstitution assemblage for use with needleless syringe
US9839580B2 (en) 2012-08-26 2017-12-12 Medimop Medical Projects, Ltd. Liquid drug transfer devices
US9943463B2 (en) 2013-05-10 2018-04-17 West Pharma. Services IL, Ltd. Medical devices including vial adapter with inline dry drug module
KR20180043261A (en) * 2015-07-17 2018-04-27 홀거 엥겔 Dry chemical containers
USD832430S1 (en) 2016-11-15 2018-10-30 West Pharma. Services IL, Ltd. Dual vial adapter assemblage
US10195112B2 (en) 2012-11-26 2019-02-05 Becton Dickinson France Adaptor for multidose medical container
US10278897B2 (en) 2015-11-25 2019-05-07 West Pharma. Services IL, Ltd. Dual vial adapter assemblage including drug vial adapter with self-sealing access valve
US10285907B2 (en) 2015-01-05 2019-05-14 West Pharma. Services IL, Ltd. Dual vial adapter assemblages with quick release drug vial adapter for ensuring correct usage
US10357429B2 (en) 2015-07-16 2019-07-23 West Pharma. Services IL, Ltd. Liquid drug transfer devices for secure telescopic snap fit on injection vials
US10646404B2 (en) 2016-05-24 2020-05-12 West Pharma. Services IL, Ltd. Dual vial adapter assemblages including identical twin vial adapters
US10688295B2 (en) 2013-08-07 2020-06-23 West Pharma. Services IL, Ltd. Liquid transfer devices for use with infusion liquid containers
US10765604B2 (en) 2016-05-24 2020-09-08 West Pharma. Services IL, Ltd. Drug vial adapter assemblages including vented drug vial adapter and vented liquid vial adapter
US10772797B2 (en) 2016-12-06 2020-09-15 West Pharma. Services IL, Ltd. Liquid drug transfer devices for use with intact discrete injection vial release tool
WO2020170169A3 (en) * 2019-02-22 2020-09-24 3M Innovative Properties Company Disinfecting cap for valves comprising a luer-activated septum
US10806671B2 (en) 2016-08-21 2020-10-20 West Pharma. Services IL, Ltd. Syringe assembly
US10806667B2 (en) 2016-06-06 2020-10-20 West Pharma. Services IL, Ltd. Fluid transfer devices for filling drug pump cartridges with liquid drug contents
USD903864S1 (en) 2018-06-20 2020-12-01 West Pharma. Services IL, Ltd. Medication mixing apparatus
US10857068B2 (en) 2016-02-24 2020-12-08 Neomed, Inc. Fluid transfer connector
US10945921B2 (en) 2017-03-29 2021-03-16 West Pharma. Services IL, Ltd. User actuated liquid drug transfer devices for use in ready-to-use (RTU) liquid drug transfer assemblages
USD917693S1 (en) 2018-07-06 2021-04-27 West Pharma. Services IL, Ltd. Medication mixing apparatus
USD923812S1 (en) 2019-01-16 2021-06-29 West Pharma. Services IL, Ltd. Medication mixing apparatus
USD923782S1 (en) 2019-01-17 2021-06-29 West Pharma. Services IL, Ltd. Medication mixing apparatus
USD954253S1 (en) 2019-04-30 2022-06-07 West Pharma. Services IL, Ltd. Liquid transfer device
USD956958S1 (en) 2020-07-13 2022-07-05 West Pharma. Services IL, Ltd. Liquid transfer device
US11642285B2 (en) 2017-09-29 2023-05-09 West Pharma. Services IL, Ltd. Dual vial adapter assemblages including twin vented female vial adapters
US11918542B2 (en) 2019-01-31 2024-03-05 West Pharma. Services IL, Ltd. Liquid transfer device

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6692478B1 (en) * 1998-05-04 2004-02-17 Paradis Joseph R Swabbable needleless vial access
US20040186457A1 (en) * 2003-03-17 2004-09-23 Truitt Timothy Lee Needleless access vial
US20080009822A1 (en) * 2003-12-18 2008-01-10 Halkey-Roberts Corporation Needleless access vial
CA2550476A1 (en) * 2003-12-18 2005-09-15 Halkey-Roberts Corporation Needleless access vial
WO2005087127A1 (en) * 2004-02-13 2005-09-22 Paradis Joeseph R Swabbable needleless vial access
US20050261637A1 (en) * 2004-05-21 2005-11-24 Halkey-Roberts Corporation T-port with swabbable valve
US7192423B2 (en) * 2004-11-17 2007-03-20 Cindy Wong Dispensing spike assembly with removable indicia bands
WO2006086331A2 (en) * 2005-02-08 2006-08-17 Cdex, Inc. Cuvette and cuvette cap
DK1957028T3 (en) * 2005-10-30 2017-09-11 Medimop Medical Projects Ltd Needleless additive control valve
US7717882B2 (en) * 2005-11-17 2010-05-18 Becton, Dickinson And Company Medical access device
US20080015539A1 (en) * 2006-02-28 2008-01-17 Robert Pieroni Bottle with adapter for receiving needleless syringe
US7547300B2 (en) * 2006-04-12 2009-06-16 Icu Medical, Inc. Vial adaptor for regulating pressure
US20080067462A1 (en) * 2006-08-09 2008-03-20 Miller Pavel T Stopcock With Swabbable Valve
US7883499B2 (en) 2007-03-09 2011-02-08 Icu Medical, Inc. Vial adaptors and vials for regulating pressure
US20080308444A1 (en) 2007-06-13 2008-12-18 Baxter International Inc. Packaging system and method of alerting a practitioner
US20080308443A1 (en) * 2007-06-13 2008-12-18 Baxter International Inc. Packaging system and method of use
WO2010022095A1 (en) * 2008-08-20 2010-02-25 Icu Medical, Inc. Anti-reflux vial adaptors
EP2474331B1 (en) 2009-07-01 2018-08-15 Fresenius Medical Care Holdings, Inc. Drug delivery devices and related systems and methods
ES2576786T3 (en) * 2010-12-14 2016-07-11 Hoffmann Neopac Ag Tube with a female Luer lock connector
CA2825524C (en) 2011-01-31 2021-03-23 Fresenius Medical Care Holdings, Inc. Preventing over-delivery of drug
CN103442744B (en) 2011-02-08 2017-02-15 弗雷塞尼斯医疗保健控股公司 Magnetic sensors and related systems and methods
CN104010616B (en) 2011-08-18 2016-09-28 Icu医学有限公司 Controlled pressure type phial joint
WO2013045619A1 (en) 2011-09-29 2013-04-04 Ge Healthcare As Package
WO2013087817A1 (en) * 2011-12-15 2013-06-20 Ge Healthcare As Package
CN104168948B (en) 2012-01-13 2017-03-01 Icu医学有限公司 Controlled pressure type phial joint and method
AU2013204180B2 (en) 2012-03-22 2016-07-21 Icu Medical, Inc. Pressure-regulating vial adaptors
US9144646B2 (en) 2012-04-25 2015-09-29 Fresenius Medical Care Holdings, Inc. Vial spiking devices and related assemblies and methods
US9089475B2 (en) 2013-01-23 2015-07-28 Icu Medical, Inc. Pressure-regulating vial adaptors
CA2899000C (en) 2013-01-23 2022-07-12 Icu Medical, Inc. Pressure-regulating vial adaptors
EP3021814A4 (en) 2013-07-19 2017-08-09 ICU Medical, Inc. Pressure-regulating fluid transfer systems and methods
JP6605511B2 (en) 2014-06-20 2019-11-13 アイシーユー・メディカル・インコーポレーテッド Pressure adjustment vial adapter
EP3397231B1 (en) 2016-01-29 2022-03-02 ICU Medical, Inc. Pressure-regulating vial adaptors
WO2018064206A1 (en) 2016-09-30 2018-04-05 Icu Medical, Inc. Pressure-regulating vial access devices and methods
WO2018213524A1 (en) 2017-05-17 2018-11-22 Klim-Loc, Llc Devices and methods for needleless extraction and administration of contents from vials
US11007120B1 (en) * 2020-10-15 2021-05-18 Klim-Loc, Llc Devices and methods for needleless and needled extraction of contents from vials

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5000745A (en) * 1988-11-18 1991-03-19 Edward Weck Incorporated Hemostatis valve
US5439451A (en) * 1994-03-22 1995-08-08 B. Braun Medical, Inc. Capless medical backcheck valve
US5620434A (en) * 1994-03-14 1997-04-15 Brony; Seth K. Medicine vial link for needleless syringes
US5700248A (en) * 1995-12-15 1997-12-23 Icu Medical, Inc. Medical valve with tire seal
US5957898A (en) * 1997-05-20 1999-09-28 Baxter International Inc. Needleless connector
US6692478B1 (en) * 1998-05-04 2004-02-17 Paradis Joseph R Swabbable needleless vial access

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332113A (en) * 1989-11-30 1994-07-26 Elan Pharmaceutical Research Corporation Cap assembly
US5429256A (en) * 1994-01-24 1995-07-04 Kestenbaum; Alan D. Drug withdrawal system for container
US5569235A (en) * 1994-06-21 1996-10-29 Modern Medical Devices Valve and valved container for use with a syringe fitting
US5895383A (en) * 1996-11-08 1999-04-20 Bracco Diagnostics Inc. Medicament container closure with recessed integral spike access means
US5902298A (en) * 1997-11-07 1999-05-11 Bracco Research Usa Medicament container stopper with integral spike access means
US5921419A (en) * 1998-05-04 1999-07-13 Bracco Research Usa Universal stopper

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5000745A (en) * 1988-11-18 1991-03-19 Edward Weck Incorporated Hemostatis valve
US5620434A (en) * 1994-03-14 1997-04-15 Brony; Seth K. Medicine vial link for needleless syringes
US5439451A (en) * 1994-03-22 1995-08-08 B. Braun Medical, Inc. Capless medical backcheck valve
US5700248A (en) * 1995-12-15 1997-12-23 Icu Medical, Inc. Medical valve with tire seal
US5957898A (en) * 1997-05-20 1999-09-28 Baxter International Inc. Needleless connector
US6692478B1 (en) * 1998-05-04 2004-02-17 Paradis Joseph R Swabbable needleless vial access

Cited By (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9205026B2 (en) 2007-08-01 2015-12-08 Hospira, Inc. Medicament admixing system
US9205025B2 (en) 2007-08-01 2015-12-08 Hospira, Inc. Medicament admixing system
US20090036861A1 (en) * 2007-08-01 2009-02-05 Hospira, Inc. Medicament admixing system
US8801689B2 (en) 2007-08-01 2014-08-12 Hospira, Inc. Medicament admixing system
US9198832B2 (en) 2007-08-01 2015-12-01 Hospira, Inc. Medicament admixing system
US20110022023A1 (en) * 2008-01-09 2011-01-27 Novartis Ag Unitary withdrawal spike unit suitable for factory fitting
US9039673B2 (en) * 2008-01-09 2015-05-26 Novartis Ag Unitary withdrawal spike unit suitable for factory fitting
US8998875B2 (en) 2009-10-01 2015-04-07 Medimop Medical Projects Ltd. Vial assemblage with vial and pre-attached fluid transfer device
US8608723B2 (en) 2009-11-12 2013-12-17 Medimop Medical Projects Ltd. Fluid transfer devices with sealing arrangement
US8979792B2 (en) 2009-11-12 2015-03-17 Medimop Medical Projects Ltd. Inline liquid drug medical devices with linear displaceable sliding flow control member
US9132063B2 (en) 2009-11-12 2015-09-15 Medimop Medical Projects Ltd. Inline liquid drug medical devices with linear displaceable sliding flow control member
US8684994B2 (en) 2010-02-24 2014-04-01 Medimop Medical Projects Ltd. Fluid transfer assembly with venting arrangement
US8753325B2 (en) 2010-02-24 2014-06-17 Medimop Medical Projects, Ltd. Liquid drug transfer device with vented vial adapter
CN103555558A (en) * 2010-07-23 2014-02-05 贝克曼考尔特公司 Vessel for real time pcr
US9285382B2 (en) * 2010-07-23 2016-03-15 Beckman Coulter, Inc. Reaction vessel
US20130196422A1 (en) * 2010-07-23 2013-08-01 Beckman Coulter, Inc. System and method including analytical units
US8852145B2 (en) 2010-11-14 2014-10-07 Medimop Medical Projects, Ltd. Inline liquid drug medical device having rotary flow control member
US9610223B2 (en) 2010-12-17 2017-04-04 Hospira, Inc. System and method for intermixing the contents of two containers
US8721612B2 (en) 2010-12-17 2014-05-13 Hospira, Inc. System and method for intermixing the contents of two containers
US20120265163A1 (en) * 2011-04-14 2012-10-18 Marc Bunjiun Cheng Coupling system to transfer material between containers
US8752598B2 (en) 2011-04-17 2014-06-17 Medimop Medical Projects Ltd. Liquid drug transfer assembly
US8882739B2 (en) 2011-10-03 2014-11-11 Hospira, Inc. System and method for mixing the contents of two containers
US9079686B2 (en) 2011-10-03 2015-07-14 Hospira, Inc. Port assembly for mixing the contents of two containers
US8911421B2 (en) 2011-10-03 2014-12-16 Hospira, Inc. System and method for mixing the contents of two containers
US8834444B2 (en) 2011-10-03 2014-09-16 Hospira, Inc. System and method for mixing the contents of two containers
US8905994B1 (en) 2011-10-11 2014-12-09 Medimop Medical Projects, Ltd. Valve assembly for use with liquid container and drug vial
USD737436S1 (en) 2012-02-13 2015-08-25 Medimop Medical Projects Ltd. Liquid drug reconstitution assembly
USD720451S1 (en) 2012-02-13 2014-12-30 Medimop Medical Projects Ltd. Liquid drug transfer assembly
US9283324B2 (en) 2012-04-05 2016-03-15 Medimop Medical Projects, Ltd Fluid transfer devices having cartridge port with cartridge ejection arrangement
US10299990B2 (en) 2012-08-26 2019-05-28 West Pharma. Services IL, Ltd. Liquid drug transfer devices
US9839580B2 (en) 2012-08-26 2017-12-12 Medimop Medical Projects, Ltd. Liquid drug transfer devices
US9795536B2 (en) 2012-08-26 2017-10-24 Medimop Medical Projects, Ltd. Liquid drug transfer devices employing manual rotation for dual flow communication step actuations
US9339438B2 (en) 2012-09-13 2016-05-17 Medimop Medical Projects Ltd. Telescopic female drug vial adapter
US10195112B2 (en) 2012-11-26 2019-02-05 Becton Dickinson France Adaptor for multidose medical container
USD734868S1 (en) 2012-11-27 2015-07-21 Medimop Medical Projects Ltd. Drug vial adapter with downwardly depending stopper
US9801786B2 (en) 2013-04-14 2017-10-31 Medimop Medical Projects Ltd. Drug container closure for mounting on open-topped drug container to form drug reconstitution assemblage for use with needleless syringe
US9943463B2 (en) 2013-05-10 2018-04-17 West Pharma. Services IL, Ltd. Medical devices including vial adapter with inline dry drug module
USD765837S1 (en) 2013-08-07 2016-09-06 Medimop Medical Projects Ltd. Liquid transfer device with integral vial adapter
USD767124S1 (en) 2013-08-07 2016-09-20 Medimop Medical Projects Ltd. Liquid transfer device with integral vial adapter
US10688295B2 (en) 2013-08-07 2020-06-23 West Pharma. Services IL, Ltd. Liquid transfer devices for use with infusion liquid containers
USD757933S1 (en) 2014-09-11 2016-05-31 Medimop Medical Projects Ltd. Dual vial adapter assemblage
US10285907B2 (en) 2015-01-05 2019-05-14 West Pharma. Services IL, Ltd. Dual vial adapter assemblages with quick release drug vial adapter for ensuring correct usage
US10357429B2 (en) 2015-07-16 2019-07-23 West Pharma. Services IL, Ltd. Liquid drug transfer devices for secure telescopic snap fit on injection vials
JP2018525623A (en) * 2015-07-17 2018-09-06 ホルガー エンゲル, Dry chemical container
KR20180043261A (en) * 2015-07-17 2018-04-27 홀거 엥겔 Dry chemical containers
KR102602904B1 (en) 2015-07-17 2023-11-16 스타트-다이아그노스티카 앤드 이노베이션, 에스.엘. dry chemical containers
US10843193B2 (en) 2015-07-17 2020-11-24 Stat-Diagnostica & Innovation, S.L. Dry chemistry container
USD801522S1 (en) 2015-11-09 2017-10-31 Medimop Medical Projects Ltd. Fluid transfer assembly
US10278897B2 (en) 2015-11-25 2019-05-07 West Pharma. Services IL, Ltd. Dual vial adapter assemblage including drug vial adapter with self-sealing access valve
US12036183B2 (en) 2016-02-24 2024-07-16 Avent, Inc. Fluid transfer connector
US10857068B2 (en) 2016-02-24 2020-12-08 Neomed, Inc. Fluid transfer connector
US10646404B2 (en) 2016-05-24 2020-05-12 West Pharma. Services IL, Ltd. Dual vial adapter assemblages including identical twin vial adapters
US10765604B2 (en) 2016-05-24 2020-09-08 West Pharma. Services IL, Ltd. Drug vial adapter assemblages including vented drug vial adapter and vented liquid vial adapter
US10806667B2 (en) 2016-06-06 2020-10-20 West Pharma. Services IL, Ltd. Fluid transfer devices for filling drug pump cartridges with liquid drug contents
US10806671B2 (en) 2016-08-21 2020-10-20 West Pharma. Services IL, Ltd. Syringe assembly
USD832430S1 (en) 2016-11-15 2018-10-30 West Pharma. Services IL, Ltd. Dual vial adapter assemblage
US11786443B2 (en) 2016-12-06 2023-10-17 West Pharma. Services IL, Ltd. Liquid transfer device with integral telescopic vial adapter for use with infusion liquid container and discrete injection vial
US10772797B2 (en) 2016-12-06 2020-09-15 West Pharma. Services IL, Ltd. Liquid drug transfer devices for use with intact discrete injection vial release tool
US10772798B2 (en) 2016-12-06 2020-09-15 West Pharma Services Il, Ltd. Liquid transfer device with integral telescopic vial adapter for use with infusion liquid container and discrete injection vial
US10945921B2 (en) 2017-03-29 2021-03-16 West Pharma. Services IL, Ltd. User actuated liquid drug transfer devices for use in ready-to-use (RTU) liquid drug transfer assemblages
US11642285B2 (en) 2017-09-29 2023-05-09 West Pharma. Services IL, Ltd. Dual vial adapter assemblages including twin vented female vial adapters
USD903864S1 (en) 2018-06-20 2020-12-01 West Pharma. Services IL, Ltd. Medication mixing apparatus
USD917693S1 (en) 2018-07-06 2021-04-27 West Pharma. Services IL, Ltd. Medication mixing apparatus
USD923812S1 (en) 2019-01-16 2021-06-29 West Pharma. Services IL, Ltd. Medication mixing apparatus
USD923782S1 (en) 2019-01-17 2021-06-29 West Pharma. Services IL, Ltd. Medication mixing apparatus
US11918542B2 (en) 2019-01-31 2024-03-05 West Pharma. Services IL, Ltd. Liquid transfer device
WO2020170169A3 (en) * 2019-02-22 2020-09-24 3M Innovative Properties Company Disinfecting cap for valves comprising a luer-activated septum
USD954253S1 (en) 2019-04-30 2022-06-07 West Pharma. Services IL, Ltd. Liquid transfer device
US11484470B2 (en) 2019-04-30 2022-11-01 West Pharma. Services IL, Ltd. Liquid transfer device with dual lumen IV spike
US11786442B2 (en) 2019-04-30 2023-10-17 West Pharma. Services IL, Ltd. Liquid transfer device with dual lumen IV spike
USD1043974S1 (en) 2019-04-30 2024-09-24 West Pharma. Services IL, Ltd. Liquid transfer device
USD956958S1 (en) 2020-07-13 2022-07-05 West Pharma. Services IL, Ltd. Liquid transfer device

Also Published As

Publication number Publication date
US6692478B1 (en) 2004-02-17

Similar Documents

Publication Publication Date Title
US6692478B1 (en) Swabbable needleless vial access
AU720748B2 (en) Container closure system
US5100394A (en) Pre-slit injection site
US5211638A (en) Pre-slit injection site
US5454409A (en) Transfer adaptors
AU743521B2 (en) A container closure with a frangible seal and a connector for a fluid transfer device
US5454805A (en) Medicine vial link for needleless syringes
US5620434A (en) Medicine vial link for needleless syringes
US7717886B2 (en) Medical valve and method of use
EP1011603B1 (en) Container cap assembly having an enclosed penetrator
US5620433A (en) Port adaptor and protector and container having same
US4484916A (en) Medical solution container and port construction
EP1029526A1 (en) Medicament container stopper with integral spike access means
AU770228B2 (en) Closure device for a medical container
HUT73300A (en) Closure for medication container
JP2006504444A (en) Overcap with tamper evident function
JPS62500427A (en) restoration equipment
WO2005087127A1 (en) Swabbable needleless vial access
JPH03133456A (en) Device for storing, preparing and using drug
IE62046B1 (en) Pre-slit injection site

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION